Insider · CIK 0001365617

Heron Patrick J

Reports to the SEC for 21 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001365617

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,772 sh	—	—	3,772
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Deferred Stock UnitsA Award	Director	AAward	+1,980 sh	—	—	1,980
2026-06-05	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+5,778 sh	—	—	32,213
2026-06-05	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.7K sh	—	—	16,667
2026-06-04	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, 10% Owner	AAward	+12.5K sh	—	—	12,500
2026-01-23	MIRMMirum Pharmaceuticals, Inc.J Other	Director	JOther	+159K sh	—	—	327,585
2026-01-23	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+131K sh	$68.48	+$9M	459,010
2025-09-26	MBXMBX Biosciences, Inc.P Purchase	Director, 10% Owner	PPurchase	+667K sh	$18.00	+$12M	5,219,440
2025-06-23	HilleVax, Inc.A Award	Director, 10% Owner	AAward	+17.2K sh	—	—	17,199
2025-06-13	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+2,646 sh	$13.08	+$34.6K	27,448
2025-06-12	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+7,609 sh	—	—	26,435
2025-06-12	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.6K sh	—	—	20,568
2025-06-05	MBXMBX Biosciences, Inc. · Stock option (right to buy)A Award	Director, 10% Owner	AAward	+16K sh	—	—	16,000
2025-06-05	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+378 sh	$13.41	+$5,069.282	24,802
2025-06-04	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+1,890 sh	$13.32	+$25.2K	24,424
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Deferred Stock UnitsA Award	Director	AAward	+3,977 sh	—	—	3,977
2025-05-29	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,703 sh	—	—	5,703
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,703 sh	—	—	0
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,268 sh	—	—	6,268
2025-05-22	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+2,520 sh	$13.65	+$34.4K	22,534
2025-05-21	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+2,520 sh	$13.66	+$34.4K	20,014
2025-05-15	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+2,520 sh	$13.62	+$34.3K	17,494
2025-05-14	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+6,300 sh	$13.76	+$86.7K	14,974
2025-05-13	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+2,374 sh	$13.76	+$32.7K	8,674
2025-05-09	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+6,300 sh	$13.60	+$85.7K	6,300
2025-03-17	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+21 sh	$43.93	+$922.61	168,672
2025-03-14	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+528 sh	$44.11	+$23.3K	168,651
2025-03-11	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+963 sh	$43.77	+$42.2K	168,123
2025-03-10	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+758 sh	$42.66	+$32.3K	166,583
2025-03-10	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+577 sh	$43.37	+$25K	167,160
2025-03-07	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+580 sh	$43.21	+$25.1K	165,825
2025-03-06	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+1,335 sh	$43.89	+$58.6K	165,245
2025-03-05	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+267 sh	$44.55	+$11.9K	163,910
2025-03-04	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+56 sh	$45.96	+$2,573.743	163,643
2025-03-04	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+1,279 sh	$45.55	+$58.3K	163,587
2024-09-18	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+115 sh	$37.40	+$4,301	162,308
2024-09-16	MBXMBX Biosciences, Inc. · Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−28.3M sh	—	—	0
2024-09-16	MBXMBX Biosciences, Inc. · Series A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−18.9M sh	—	—	0
2024-09-16	MBXMBX Biosciences, Inc.P Purchase	Director, 10% Owner	PPurchase	+625K sh	$16.00	+$10M	4,552,774
2024-09-16	MBXMBX Biosciences, Inc.C Conversion	Director, 10% Owner	CConversion	+3.93M sh	—	—	3,927,774
2024-09-12	MBXMBX Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+16K sh	—	—	15,963
2024-09-06	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+230 sh	$41.58	+$9,563.009	162,193
2024-06-14	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.1K sh	—	—	27,052
2024-06-14	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+10.1K sh	—	—	18,826
2024-06-06	HilleVax, Inc.Stock OptionA Award	Director, 10% Owner	AAward	+22.5K sh	—	—	22,500
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+5,703 sh	—	—	5,703
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,779 sh	—	—	8,779
2024-03-04	ARQTArcutis Biotherapeutics, Inc.P Purchase	Director	PPurchase	+21.1K sh	$9.50	+$200K	8,785,284
2023-11-09	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+2,910 sh	$28.30	+$82.4K	161,963
2023-09-13	MIRMMirum Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+2,625 sh	$31.02	+$81.4K	159,053

Recent filings

Accepted (ET)
Jun 174
Heron Patrick J0001365617-26-000004
SEC(opens sec.gov)
Jun 94
Heron Patrick J0001628280-26-042046
SEC(opens sec.gov)
Jun 54
Heron Patrick J0001193125-26-258435
SEC(opens sec.gov)
Jan 274
Heron Patrick J0001365617-26-000002
SEC(opens sec.gov)
Sep 304
Topper James N0001231919-25-000267
SEC(opens sec.gov)
Jun 254
Heron Patrick J0000950170-25-090020
SEC(opens sec.gov)
Jun 174
Heron Patrick J0001415889-25-017576
SEC(opens sec.gov)
Jun 164
Heron Patrick J0002065881-25-000027
SEC(opens sec.gov)
Jun 64
Heron Patrick J0001415889-25-015883
SEC(opens sec.gov)
Jun 64
Heron Patrick J0000950170-25-082699
SEC(opens sec.gov)
Jun 24
Heron Patrick J0001415889-25-015305
SEC(opens sec.gov)
May 234
Heron Patrick J0001415889-25-014415
SEC(opens sec.gov)

Address

C/O MIRUM PHARMACEUTICALS, INC. 989 E. HILLSDALE BLVD., SUITE 300

FOSTER CITY, CA, 94404